Format
Sort by

Send to

Choose Destination

Search results

Items: 5

2.

Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.

Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, Lampropoulos AF; LYSISTRATA study group.

Eur J Cancer Prev. 2014 Sep;23(5):425-31. doi: 10.1097/CEJ.0000000000000060.

PMID:
24977385
3.

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.

Sotiriadis A, Dagklis T, Siamanta V, Chatzigeorgiou K, Agorastos T; LYSISTRATA Study Group.

Arch Gynecol Obstet. 2012 Jun;285(6):1719-24. doi: 10.1007/s00404-011-2208-z. Epub 2012 Jan 14.

PMID:
22246478
4.

Semantic integration of cervical cancer data repositories to facilitate multicenter association studies: the ASSIST approach.

Agorastos T, Koutkias V, Falelakis M, Lekka I, Mikos T, Delopoulos A, Mitkas PA, Tantsis A, Weyers S, Coorevits P, Kaufmann AM, Kurzeja R, Maglaveras N.

Cancer Inform. 2009 Feb 3;8:31-44.

5.

Levonorgestrel-releasing intrauterine system vs. endometrial thermal ablation for menorrhagia.

Theodoridis TD, Zepiridis L, Zafrakas M, Grimbizis G, Tantsis A, Kyrou D, Bontis JN.

Hormones (Athens). 2009 Jan-Mar;8(1):60-4.

Supplemental Content

Loading ...
Support Center